Stay updated on Dapagliflozin and Autonomic Function in T2D Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.

Latest updates to the Dapagliflozin and Autonomic Function in T2D Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%
- Check17 days agoChange DetectedShift the page focus from general public health topics to drug development and evaluation topics, with an updated version (v3.1.0) and removal of several public health topics (v3.0.2).SummaryDifference0.9%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to public health practices and investigative techniques. Notably, specific medications such as dapagliflozin and glimepiride have been retained, while many related medical topics and terms have been removed.SummaryDifference3%
- Check53 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dapagliflozin and Autonomic Function in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.